Suggestions
Kevin Ngan
Scientist I at Tessera Therapeutics
Kevin Ngan, a recent PhD graduate from Harvard University in the Department of Chemistry and Chemical Biology, specialized in investigating protein structure-function relationships using various approaches such as genetic, biochemical, molecular biology, and computational methods.
He conducted research focused on transcriptional and gene expression regulation proteins, primarily dealing with transcription factors, through in situ mutagenesis techniques under the guidance of Dr. Brian Liau.
Currently, Kevin serves as a scientist at Tessera Therapeutics, specifically contributing to the Synthetic Biology Group.
His research interests and expertise revolve around epigenomics, functional genomics, genome editing, CRISPR-Cas9 technology, DNA methylation, nuclear organization, and chromatin biology.
Kevin holds a Doctor of Philosophy (PhD) degree from Harvard University and a Bachelor of Science (B.S.) degree from Tufts University.
His professional background includes roles such as Scientist I at Tessera Therapeutics, PhD Candidate at Harvard University, Research Associate at Glympse Bio, and Undergraduate Researcher at Tufts University.
